APO Research
Talk to an analyst

APO RESEARCH · REPORT

Women’s Health Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Women’s Health Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025194 pages

Choose your research edition.

Industry ResearchWomen’s Health Drugs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Women’s Health Drugs Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Women’s Health Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Women’s Health Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Women’s Health Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Women’s Health Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Women’s Health Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Women’s Health Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Women’s Health Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Women’s Health Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Women’s Health Drugs include Johnson & Johnson, Novartis AG, Merck & Co, Mylan N.V., Pfizer Inc, Bayer AG, Amgen, Lupin (India) and Ferring Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Women’s Health Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Women’s Health Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Women’s Health Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Women’s Health Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Women’s Health Drugs Segment by Company

Johnson & Johnson

Novartis AG

Merck & Co

Mylan N.V.

Pfizer Inc

Bayer AG

Amgen

Lupin (India)

Ferring Pharmaceuticals

Eli Lilly And Company

Allergan

Agile Therapeutics Inc

Women’s Health Drugs Segment by Type

Minastrin 24 Fe

XGEVA

Prolia

Mirena

EVISTA

Zometa

Reclast/Aclasta

Others (Premarin, ACTONEL, ORTHO TRI-CY LO)

Women’s Health Drugs Segment by Application

Contraceptives

Polycystic Ovary Syndrome

Hormonal Infertility

Menopause

Postmenopausal Osteoporosis

Endometriosis

Other Applications

Women’s Health Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women’s Health Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Women’s Health Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women’s Health Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Women’s Health Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Women’s Health Drugs industry.

Chapter 3: Detailed analysis of Women’s Health Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Women’s Health Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Women’s Health Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Minastrin 24 Fe Table 3. Key Players of XGEVA Table 4. Key Players of Prolia Table 3. Key Players of Mirena Table 4. Key Players of EVISTA Table 5. Key Players of Zometa Table 6. Key Players of Reclast/Aclasta Table 7. Key Players of Others (Premarin, ACTONEL, ORTHO TRI-CY LO) Table 8. Global Women’s Health Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 9. Key Players of Contraceptives Table 10. Key Players of Polycystic Ovary Syndrome Table 11. Key Players of Hormonal Infertility Table 12. Key Players of Menopause Table 13. Key Players of Postmenopausal Osteoporosis Table 14. Key Players of Endometriosis Table 15. Key Players of Other Applications Table 16. Global Women’s Health Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Women’s Health Drugs Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Women’s Health Drugs Market Share by Region (2021-2026) Table 19. Global Women’s Health Drugs Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Women’s Health Drugs Market Share by Region (2027-2032) Table 21. Women’s Health Drugs Industry Trends Table 22. Women’s Health Drugs Industry Drivers Table 23. Women’s Health Drugs Industry Opportunities and Challenges Table 24. Women’s Health Drugs Industry Restraints Table 25. Global Women’s Health Drugs Revenue by Company (US$ Million) & (2021-2026) Table 26. Global Women’s Health Drugs Revenue Market Share by Company (2021-2026) Table 27. Global Women’s Health Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 28. Global Women’s Health Drugs Key Company Head Office and Area Served Table 29. Global Women’s Health Drugs Company, Product Type & Application Table 30. Global Women’s Health Drugs Company Establishment Date Table 31. Global Company Market Concentration Ratio (CR5 and HHI) Table 32. Global Women’s Health Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 33. Global Women’s Health Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Women’s Health Drugs Market Size by Type (2021-2026) & (US$ Million) Table 35. Global Women’s Health Drugs Market Size by Type (2027-2032) & (US$ Million) Table 36. Global Women’s Health Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Women’s Health Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Women’s Health Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Women’s Health Drugs Market Size by Application (2021-2026) & (US$ Million) Table 40. Global Women’s Health Drugs Market Size by Application (2027-2032) & (US$ Million) Table 41. Global Women’s Health Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Women’s Health Drugs Revenue Market Share by Application (2027-2032) Table 43. Johnson & Johnson Company Information Table 44. Johnson & Johnson Business Overview Table 45. Johnson & Johnson Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Johnson & Johnson Women’s Health Drugs Product Portfolio Table 47. Johnson & Johnson Recent Development Table 48. Novartis AG Company Information Table 49. Novartis AG Business Overview Table 50. Novartis AG Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Novartis AG Women’s Health Drugs Product Portfolio Table 52. Novartis AG Recent Development Table 53. Merck & Co Company Information Table 54. Merck & Co Business Overview Table 55. Merck & Co Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Merck & Co Women’s Health Drugs Product Portfolio Table 57. Merck & Co Recent Development Table 58. Mylan N.V. Company Information Table 59. Mylan N.V. Business Overview Table 60. Mylan N.V. Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Mylan N.V. Women’s Health Drugs Product Portfolio Table 62. Mylan N.V. Recent Development Table 63. Pfizer Inc Company Information Table 64. Pfizer Inc Business Overview Table 65. Pfizer Inc Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Pfizer Inc Women’s Health Drugs Product Portfolio Table 67. Pfizer Inc Recent Development Table 68. Bayer AG Company Information Table 69. Bayer AG Business Overview Table 70. Bayer AG Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Bayer AG Women’s Health Drugs Product Portfolio Table 72. Bayer AG Recent Development Table 73. Amgen Company Information Table 74. Amgen Business Overview Table 75. Amgen Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Amgen Women’s Health Drugs Product Portfolio Table 77. Amgen Recent Development Table 78. Lupin (India) Company Information Table 79. Lupin (India) Business Overview Table 80. Lupin (India) Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Lupin (India) Women’s Health Drugs Product Portfolio Table 82. Lupin (India) Recent Development Table 83. Ferring Pharmaceuticals Company Information Table 84. Ferring Pharmaceuticals Business Overview Table 85. Ferring Pharmaceuticals Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Ferring Pharmaceuticals Women’s Health Drugs Product Portfolio Table 87. Ferring Pharmaceuticals Recent Development Table 88. Eli Lilly And Company Company Information Table 89. Eli Lilly And Company Business Overview Table 90. Eli Lilly And Company Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Eli Lilly And Company Women’s Health Drugs Product Portfolio Table 92. Eli Lilly And Company Recent Development Table 93. Allergan Company Information Table 94. Allergan Business Overview Table 95. Allergan Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Allergan Women’s Health Drugs Product Portfolio Table 97. Allergan Recent Development Table 98. Agile Therapeutics Inc Company Information Table 99. Agile Therapeutics Inc Business Overview Table 100. Agile Therapeutics Inc Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Agile Therapeutics Inc Women’s Health Drugs Product Portfolio Table 102. Agile Therapeutics Inc Recent Development Table 103. North America Women’s Health Drugs Market Size by Type (2021-2026) & (US$ Million) Table 104. North America Women’s Health Drugs Market Size by Type (2027-2032) & (US$ Million) Table 105. North America Women’s Health Drugs Market Size by Application (2021-2026) & (US$ Million) Table 106. North America Women’s Health Drugs Market Size by Application (2027-2032) & (US$ Million) Table 107. North America Women’s Health Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Women’s Health Drugs Market Size by Country (2021-2026) Table 109. North America Women’s Health Drugs Market Size by Country (2027-2032) Table 110. Europe Women’s Health Drugs Market Size by Type (2021-2026) & (US$ Million) Table 111. Europe Women’s Health Drugs Market Size by Type (2027-2032) & (US$ Million) Table 112. Europe Women’s Health Drugs Market Size by Application (2021-2026) & (US$ Million) Table 113. Europe Women’s Health Drugs Market Size by Application (2027-2032) & (US$ Million) Table 114. Europe Women’s Health Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Women’s Health Drugs Market Size by Country (2021-2026) Table 116. Europe Women’s Health Drugs Market Size by Country (2027-2032) Table 117. China Women’s Health Drugs Market Size by Type (2021-2026) & (US$ Million) Table 118. China Women’s Health Drugs Market Size by Type (2027-2032) & (US$ Million) Table 119. China Women’s Health Drugs Market Size by Application (2021-2026) & (US$ Million) Table 120. China Women’s Health Drugs Market Size by Application (2027-2032) & (US$ Million) Table 121. Asia Women’s Health Drugs Market Size by Type (2021-2026) & (US$ Million) Table 122. Asia Women’s Health Drugs Market Size by Type (2027-2032) & (US$ Million) Table 123. Asia Women’s Health Drugs Market Size by Application (2021-2026) & (US$ Million) Table 124. Asia Women’s Health Drugs Market Size by Application (2027-2032) & (US$ Million) Table 125. Asia Women’s Health Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Asia Women’s Health Drugs Market Size by Country (2021-2026) Table 127. Asia Women’s Health Drugs Market Size by Country (2027-2032) Table 128. South America, Middle East & Africa Women’s Health Drugs Market Size by Type (2021-2026) & (US$ Million) Table 129. South America, Middle East & Africa Women’s Health Drugs Market Size by Type (2027-2032) & (US$ Million) Table 130. South America, Middle East & Africa Women’s Health Drugs Market Size by Application (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa Women’s Health Drugs Market Size by Application (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa Women’s Health Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. South America, Middle East & Africa Women’s Health Drugs Market Size by Country (2021-2026) Table 134. South America, Middle East & Africa Women’s Health Drugs Market Size by Country (2027-2032) Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Women’s Health Drugs Product Image Figure 2. Global Women’s Health Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Women’s Health Drugs Market Share by Type: 2025 VS 2032 Figure 4. Minastrin 24 Fe Image Figure 5. XGEVA Image Figure 6. Prolia Image Figure 7. Mirena Image Figure 8. EVISTA Image Figure 9. Zometa Image Figure 10. Reclast/Aclasta Image Figure 11. Others (Premarin, ACTONEL, ORTHO TRI-CY LO) Image Figure 12. Global Women’s Health Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Women’s Health Drugs Market Share by Application: 2025 VS 2032 Figure 14. Contraceptives Image Figure 15. Polycystic Ovary Syndrome Image Figure 16. Hormonal Infertility Image Figure 17. Menopause Image Figure 18. Postmenopausal Osteoporosis Image Figure 19. Endometriosis Image Figure 20. Other Applications Image Figure 21. Global Women’s Health Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 22. Global Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 23. Global Women’s Health Drugs Market Share by Region: 2025 VS 2032 Figure 24. Years Considered Figure 25. Global Women’s Health Drugs Market Share by Players in 2025 Figure 26. Global Top 5 and 10 Women’s Health Drugs Players Market Share by Revenue in 2025 Figure 27. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Women’s Health Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Women’s Health Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Women’s Health Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Women’s Health Drugs Revenue Market Share by Application (2021-2032) Figure 32. North America Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 33. North America Women’s Health Drugs Market Share by Type (2021-2032) Figure 34. North America Women’s Health Drugs Market Share by Application (2021-2032) Figure 35. North America Women’s Health Drugs Market Share by Country (2021-2032) Figure 36. United States Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 37. Canada Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Mexico Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Europe Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Europe Women’s Health Drugs Market Share by Type (2021-2032) Figure 41. Europe Women’s Health Drugs Market Share by Application (2021-2032) Figure 42. Europe Women’s Health Drugs Market Share by Country (2021-2032) Figure 43. Germany Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 44. France Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 45. U.K. Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 46. Italy Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 47. Russia Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 48. Nordic Countries Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 49. China Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 50. China Women’s Health Drugs Market Share by Type (2021-2032) Figure 51. China Women’s Health Drugs Market Share by Application (2021-2032) Figure 52. Asia Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 53. Asia Women’s Health Drugs Market Share by Type (2021-2032) Figure 54. Asia Women’s Health Drugs Market Share by Application (2021-2032) Figure 55. Asia Women’s Health Drugs Market Share by Country (2021-2032) Figure 56. Japan Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 57. South Korea Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 58. Taiwan Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 59. Southeast Asia Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 60. India Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Australia Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 62. South America, Middle East & Africa Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 63. South America, Middle East & Africa Women’s Health Drugs Market Share by Type (2021-2032) Figure 64. South America, Middle East & Africa Women’s Health Drugs Market Share by Application (2021-2032) Figure 65. South America, Middle East & Africa Women’s Health Drugs Market Share by Country (2021-2032) Figure 66. Brazil Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 67. South Africa Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 68. Saudi Arabia Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 69. Turkey Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 70. Argentina Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 71. UAE Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 72. Egypt Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 73. Chile Women’s Health Drugs Market Size (2021-2032) & (US$ Million) Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Minastrin 24 Fe
  • XGEVA
  • Prolia
  • Mirena
  • EVISTA
  • Zometa
  • Reclast/Aclasta
  • Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
Applications
  • Contraceptives
  • Polycystic Ovary Syndrome
  • Hormonal Infertility
  • Menopause
  • Postmenopausal Osteoporosis
  • Endometriosis
  • Other Applications
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • Merck & Co
  • Mylan N.V.
  • Pfizer Inc
  • Bayer AG
  • Amgen
  • Lupin (India)
  • Ferring Pharmaceuticals
  • Eli Lilly And Company
  • Allergan
  • Agile Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Women’s Health Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Minastrin 24 Fe
  5. 1.2.3 XGEVA
  6. 1.2.4 Prolia
  7. 1.2.5 Mirena
  8. 1.2.6 EVISTA
  9. 1.2.7 Zometa
  10. 1.2.8 Reclast/Aclasta
  11. 1.2.9 Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
  12. 1.3 Market Analysis by Application
  13. 1.3.1 Global Women’s Health Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  14. 1.3.2 Contraceptives
  15. 1.3.3 Polycystic Ovary Syndrome
  16. 1.3.4 Hormonal Infertility
  17. 1.3.5 Menopause
  18. 1.3.6 Postmenopausal Osteoporosis
  19. 1.3.7 Endometriosis
  20. 1.3.8 Other Applications
  21. 1.4 Global Market Growth Prospects
  22. 1.5 Global Women’s Health Drugs Growth Trends by Region
  23. 1.5.1 Global Women’s Health Drugs Market Size by Region: 2021 VS 2025 VS 2032
  24. 1.5.2 Women’s Health Drugs Market Size by Region (2021-2026)
  25. 1.5.3 Women’s Health Drugs Market Size by Region (2027-2032)
  26. 1.6 Assumptions and Limitations
  27. 1.7 Study Goals and Objectives
  28. 1.8 Years Considered
2 Global Women’s Health Drugs Market Dynamics
  1. 2.1 Women’s Health Drugs Industry Trends
  2. 2.2 Women’s Health Drugs Industry Drivers
  3. 2.3 Women’s Health Drugs Industry Opportunities and Challenges
  4. 2.4 Women’s Health Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Women’s Health Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Women’s Health Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Women’s Health Drugs Key Company Head office and Area Served
  4. 3.4 Global Women’s Health Drugs Company, Product Type & Application
  5. 3.5 Global Women’s Health Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Women’s Health Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Women’s Health Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Women’s Health Drugs Tier 1, Tier 2, and Tier 3
4 Women’s Health Drugs Market by Type
  1. 4.1 Global Women’s Health Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Women’s Health Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Women’s Health Drugs Market Size Share by Type (2021-2032)
5 Women’s Health Drugs Market by Application
  1. 5.1 Global Women’s Health Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Women’s Health Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Women’s Health Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Johnson & Johnson Women’s Health Drugs Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis AG Women’s Health Drugs Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Merck & Co
  14. 6.3.1 Merck & Co Company Information
  15. 6.3.2 Merck & Co Business Overview
  16. 6.3.3 Merck & Co Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Merck & Co Women’s Health Drugs Product Portfolio
  18. 6.3.5 Merck & Co Recent Developments
  19. 6.4 Mylan N.V.
  20. 6.4.1 Mylan N.V. Company Information
  21. 6.4.2 Mylan N.V. Business Overview
  22. 6.4.3 Mylan N.V. Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Mylan N.V. Women’s Health Drugs Product Portfolio
  24. 6.4.5 Mylan N.V. Recent Developments
  25. 6.5 Pfizer Inc
  26. 6.5.1 Pfizer Inc Company Information
  27. 6.5.2 Pfizer Inc Business Overview
  28. 6.5.3 Pfizer Inc Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pfizer Inc Women’s Health Drugs Product Portfolio
  30. 6.5.5 Pfizer Inc Recent Developments
  31. 6.6 Bayer AG
  32. 6.6.1 Bayer AG Company Information
  33. 6.6.2 Bayer AG Business Overview
  34. 6.6.3 Bayer AG Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bayer AG Women’s Health Drugs Product Portfolio
  36. 6.6.5 Bayer AG Recent Developments
  37. 6.7 Amgen
  38. 6.7.1 Amgen Company Information
  39. 6.7.2 Amgen Business Overview
  40. 6.7.3 Amgen Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Amgen Women’s Health Drugs Product Portfolio
  42. 6.7.5 Amgen Recent Developments
  43. 6.8 Lupin (India)
  44. 6.8.1 Lupin (India) Company Information
  45. 6.8.2 Lupin (India) Business Overview
  46. 6.8.3 Lupin (India) Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Lupin (India) Women’s Health Drugs Product Portfolio
  48. 6.8.5 Lupin (India) Recent Developments
  49. 6.9 Ferring Pharmaceuticals
  50. 6.9.1 Ferring Pharmaceuticals Company Information
  51. 6.9.2 Ferring Pharmaceuticals Business Overview
  52. 6.9.3 Ferring Pharmaceuticals Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Ferring Pharmaceuticals Women’s Health Drugs Product Portfolio
  54. 6.9.5 Ferring Pharmaceuticals Recent Developments
  55. 6.10 Eli Lilly And Company
  56. 6.10.1 Eli Lilly And Company Company Information
  57. 6.10.2 Eli Lilly And Company Business Overview
  58. 6.10.3 Eli Lilly And Company Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Eli Lilly And Company Women’s Health Drugs Product Portfolio
  60. 6.10.5 Eli Lilly And Company Recent Developments
  61. 6.11 Allergan
  62. 6.11.1 Allergan Company Information
  63. 6.11.2 Allergan Business Overview
  64. 6.11.3 Allergan Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Allergan Women’s Health Drugs Product Portfolio
  66. 6.11.5 Allergan Recent Developments
  67. 6.12 Agile Therapeutics Inc
  68. 6.12.1 Agile Therapeutics Inc Company Information
  69. 6.12.2 Agile Therapeutics Inc Business Overview
  70. 6.12.3 Agile Therapeutics Inc Women’s Health Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Agile Therapeutics Inc Women’s Health Drugs Product Portfolio
  72. 6.12.5 Agile Therapeutics Inc Recent Developments
7 North America
  1. 7.1 North America Women’s Health Drugs Market Size (2021-2032)
  2. 7.2 North America Women’s Health Drugs Market Size by Type
  3. 7.2.1 North America Women’s Health Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Women’s Health Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Women’s Health Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Women’s Health Drugs Market Size by Application
  7. 7.3.1 North America Women’s Health Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Women’s Health Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Women’s Health Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Women’s Health Drugs Market Size by Country
  11. 7.4.1 North America Women’s Health Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Women’s Health Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Women’s Health Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Women’s Health Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Women’s Health Drugs Market Size (2021-2032)
  2. 8.2 Europe Women’s Health Drugs Market Size by Type
  3. 8.2.1 Europe Women’s Health Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Women’s Health Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Women’s Health Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Women’s Health Drugs Market Size by Application
  7. 8.3.1 Europe Women’s Health Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Women’s Health Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Women’s Health Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Women’s Health Drugs Market Size by Country
  11. 8.4.1 Europe Women’s Health Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Women’s Health Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Women’s Health Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Women’s Health Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Women’s Health Drugs Market Size (2021-2032)
  2. 9.2 China Women’s Health Drugs Market Size by Type
  3. 9.2.1 China Women’s Health Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Women’s Health Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Women’s Health Drugs Market Share by Type (2021-2032)
  6. 9.3 China Women’s Health Drugs Market Size by Application
  7. 9.3.1 China Women’s Health Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Women’s Health Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Women’s Health Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Women’s Health Drugs Market Size (2021-2032)
  2. 10.2 Asia Women’s Health Drugs Market Size by Type
  3. 10.2.1 Asia Women’s Health Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Women’s Health Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Women’s Health Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Women’s Health Drugs Market Size by Application
  7. 10.3.1 Asia Women’s Health Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Women’s Health Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Women’s Health Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Women’s Health Drugs Market Size by Country
  11. 10.4.1 Asia Women’s Health Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Women’s Health Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Women’s Health Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Women’s Health Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Women’s Health Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Women’s Health Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Women’s Health Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Women’s Health Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Women’s Health Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Women’s Health Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Women’s Health Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Women’s Health Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Women’s Health Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Women’s Health Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Women’s Health Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Women’s Health Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Women’s Health Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Women’s Health Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst